PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32002777-3	2020	In the present study, daily doses of Sal were administered to APP/PS1 mice, a mouse model of AD, and several parameters were tested, including behavioral performance, Abeta status, levels of synapse-related proteins, and levels of PI3K/Akt targets of mTOR cell signaling pathway proteins.	rhodioloside	37-40	thymoma viral proto-oncogene 1	Mus musculus	236-239	
32002777-6	2020	The phosphatidylinositide PI3K/Akt/mTOR signaling was upregulated, which was in accordance with the above improvements from Sal treatment.	rhodioloside	124-127	thymoma viral proto-oncogene 1	Mus musculus	31-34